Literature DB >> 4208047

Sensitization of E. coli to the serum bactericidal system and to lysozyme by ethyleneglycoltetraacetic acid.

C S Bryan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4208047     DOI: 10.3181/00379727-145-38028

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  10 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.

Authors:  C W Cutler; J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

4.  Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin.

Authors:  R T Ellison; T J Giehl; F M LaForce
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

5.  A possible role of Eubacterium and Peptostreptococcus species in the aetiology of Crohn's disease.

Authors:  J P van de Merwe; G J Mol
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

6.  Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.

Authors:  R M Des Prez; C S Bryan; J Hawiger; D G Colley
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

7.  Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Emergence of bactericidal and opsonizing antibody to Vibrio vulnificus following bacterial infection.

Authors:  D M Musher; M V Hansen; A Goree; F Gyorkey; A J Chapman; R E Baughn
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

9.  The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.

Authors:  A W Hill; A L Shears; K G Hibbitt
Journal:  Immunology       Date:  1978-01       Impact factor: 7.397

10.  Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae.

Authors:  H Schneider; J M Griffiss; R E Mandrell; G A Jarvis
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.